Crossmark

Feasibly of axitinib as first-line therapy for advanced or metastatic renal cell carcinoma: a single-institution experience in Japan

Crossref DOI link: https://doi.org/10.1186/s12894-015-0027-4

Published Online: 2015-04-16

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Koie, Takuya

Ohyama, Chikara

Yoneyama, Takahiro

Yamamoto, Hayato

Imai, Atsushi

Hatakeyama, Shingo

Hashimoto, Yasuhiro

Yoneyama, Tohru

Tobisawa, Yuki

Mori, Kazuyuki
License Information

License valid from 2015-04-16
More Information

Article History

Received: 29 September 2014

Accepted: 7 April 2015

First Online: 16 April 2015